DEAD

Serial Number

88418271

Owner

CRANBURY PHARMACEUTICALS

Attorney

Cathy Kodroff

Filing Date

May 7, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

CP CRANBURY PHARMACEUTICALS Trademark

Serial Number: 88418271

CP CRANBURY PHARMACEUTICALS is a trademark filed by CRANBURY PHARMACEUTICALS on May 7, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

CRANBURY PHARMACEUTICALS (4 trademarks)

2031 US Highway 130
Monmouth Junction, NJ 08852

Entity Type: 16

Legal Representation

Attorney of Record

Cathy Kodroff

13 trademarks filed View all →

Trademark Details

Filing Date

May 7, 2019

Registration Date

Not Registered

Published for Opposition

September 29, 2020

Goods & Services

Prescription and non-prescription pharmaceutical medicines and preparations for the treatment of cold and allergy symptoms, respiratory disease, asthma and chronic lung disease, upper respiratory symptoms, coughs, central nervous system disorders, namely, narcolepsy and attention deficit hyperactivity disorder, for the treatment of autism, schizophrenia, bipolar disorder, convulsions, epilepsy, nausea, vomiting, pruritus, for inducing sedation, for pain relief, and for anti-inflammation; dietary supplements; nutritional supplements; vitamins; nutritional supplements in the nature of nutriceuticals for use in treating nutritional deficiencies and as dietary supplements

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Dec 26, 2023 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Dec 25, 2023 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 18, 2023 EXRA

SOU EXTENSION 5 GRANTED

May 17, 2023 EX5G

SOU EXTENSION 5 FILED

May 12, 2023 EXT5

SOU TEAS EXTENSION RECEIVED

May 12, 2023 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 5, 2022 EXRA

SOU EXTENSION 4 GRANTED

Nov 3, 2022 EX4G

SOU EXTENSION 4 FILED

Nov 3, 2022 EXT4

SOU TEAS EXTENSION RECEIVED

Nov 3, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 29, 2022 EXRA

SOU EXTENSION 3 GRANTED

Apr 27, 2022 EX3G

SOU EXTENSION 3 FILED

Apr 27, 2022 EXT3

SOU TEAS EXTENSION RECEIVED

Apr 27, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 25, 2021 EXRA

SOU EXTENSION 2 GRANTED

Nov 23, 2021 EX2G

SOU EXTENSION 2 FILED

Nov 23, 2021 EXT2

SOU TEAS EXTENSION RECEIVED

Nov 23, 2021 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 23, 2021 EXRA

SOU EXTENSION 1 GRANTED

Jun 22, 2021 EX1G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 22, 2021 AITU

NOTICE OF REVIVAL - E-MAILED

May 27, 2021 NREV

SOU EXTENSION RECEIVED WITH TEAS PETITION

May 27, 2021 TPEX

PETITION TO REVIVE-GRANTED

May 27, 2021 PETG

TEAS PETITION TO REVIVE RECEIVED

May 27, 2021 PROA

SOU EXTENSION 1 FILED

May 24, 2021 EXT1

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 24, 2020 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 29, 2020 NPUB

PUBLISHED FOR OPPOSITION

Sep 29, 2020 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 9, 2020 NONP

EXPARTE APPEAL TERMINATED

Aug 25, 2020 EXPT

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 25, 2020 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 20, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 20, 2020 CRFA

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Aug 18, 2020 ERFR

EX PARTE APPEAL-INSTITUTED

Aug 18, 2020 EXPI

JURISDICTION RESTORED TO EXAMINING ATTORNEY

Aug 18, 2020 JURT

EXPARTE APPEAL RECEIVED AT TTAB

Aug 18, 2020 EXAF

NOTIFICATION OF FINAL REFUSAL EMAILED

Feb 19, 2020 GNFN

FINAL REFUSAL E-MAILED

Feb 19, 2020 GNFR

FINAL REFUSAL WRITTEN

Feb 19, 2020 CNFR

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 29, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 29, 2020 CRFA

ASSIGNED TO LIE

Jan 29, 2020 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 23, 2020 TROA

NOTIFICATION OF PRIORITY ACTION E-MAILED

Jul 25, 2019 GPRN

PRIORITY ACTION E-MAILED

Jul 25, 2019 GPRA

PRIORITY ACTION WRITTEN

Jul 25, 2019 CPRA

PRIORITY ACTION WRITTEN

Jul 25, 2019 CPRA

ASSIGNED TO EXAMINER

Jul 22, 2019 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

May 23, 2019 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 22, 2019 NWOS

NEW APPLICATION ENTERED

May 10, 2019 NWAP

Related Trademarks

More from this Owner

CRANBURY CONNECTS

CP CRANBURY PHARMACEUTICALS

More in Same Class